---
figid: PMC7520283__JCMM-24-9518-g003
figlink: pmc/articles/PMC7520283/figure/jcmm15669-fig-0003/
number: F3
caption: Activated NF‐κB signalling pathway in OA‐FLS inflammation. CTGF promoted
  the generation of IL‐6 in human OA‐FLS through the ανβ5 integrin, ASK1, p38/JNK
  and AP‐1/NF‐kB signal transduction pathways. CTGF‐induced IL‐β in human OA‐FLS through
  αvβ3/ανβ5 integrins, ROS, and ASK1, p38/JNK, and NF‐κB signal transduction pathways,
  which attenuated by berberine, an anti‐inflammatory isoquinoline alkaloid separated
  from the Chinese herb Rhizoma coptidis (Huang Lian). CTGF enhanced MCP‐1 production
  in human OA‐FLS through the ανβ5 integrin, FAK, MEK, ERK and NF‐κB/AP‐1 signalling
  pathway. FSLT1 elevated TNF‐α, IL‐1β and IL‐6 generation in human OA‐FLS via activated
  NF‐κB signalling pathway. FSLT1 increased OA‐FLS proliferation by down‐regulating
  p53 and p21. Moreover, p21 was reported to block the elevated IL‐6 and MMPs, participated
  in the development of OA. WY‐14643, an agonist of PPAR‐α, decreased LPS‐induced
  NO, PGE2, inflammatory mediators (VCAM‐1, ICAM‐1, ET‐1 and TF), and pro‐inflammatory
  cytokines (IL‐6, IL‐1β, TNF‐α and MCP‐1) production in human OA‐FLS by suppressing
  LPS‐mediated NF‐κB activation and IkB phosphorylation. p53, a tumour‐suppressor
  protein. p21, a cyclin‐dependent kinase inhibitor
pmcid: PMC7520283
papertitle: 'The emerging role of fibroblast‐like synoviocytes‐mediated synovitis
  in osteoarthritis: An update.'
reftext: Dafei Han, et al. J Cell Mol Med. 2020 Sep;24(17):9518-9532.
pmc_ranked_result_index: '20617'
pathway_score: 0.8765699
filename: JCMM-24-9518-g003.jpg
figtitle: Activated NF‐KB signalling pathway in OA‐FLS inflammation
year: '2020'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7520283__JCMM-24-9518-g003.html
  '@type': Dataset
  description: Activated NF‐κB signalling pathway in OA‐FLS inflammation. CTGF promoted
    the generation of IL‐6 in human OA‐FLS through the ανβ5 integrin, ASK1, p38/JNK
    and AP‐1/NF‐kB signal transduction pathways. CTGF‐induced IL‐β in human OA‐FLS
    through αvβ3/ανβ5 integrins, ROS, and ASK1, p38/JNK, and NF‐κB signal transduction
    pathways, which attenuated by berberine, an anti‐inflammatory isoquinoline alkaloid
    separated from the Chinese herb Rhizoma coptidis (Huang Lian). CTGF enhanced MCP‐1
    production in human OA‐FLS through the ανβ5 integrin, FAK, MEK, ERK and NF‐κB/AP‐1
    signalling pathway. FSLT1 elevated TNF‐α, IL‐1β and IL‐6 generation in human OA‐FLS
    via activated NF‐κB signalling pathway. FSLT1 increased OA‐FLS proliferation by
    down‐regulating p53 and p21. Moreover, p21 was reported to block the elevated
    IL‐6 and MMPs, participated in the development of OA. WY‐14643, an agonist of
    PPAR‐α, decreased LPS‐induced NO, PGE2, inflammatory mediators (VCAM‐1, ICAM‐1,
    ET‐1 and TF), and pro‐inflammatory cytokines (IL‐6, IL‐1β, TNF‐α and MCP‐1) production
    in human OA‐FLS by suppressing LPS‐mediated NF‐κB activation and IkB phosphorylation.
    p53, a tumour‐suppressor protein. p21, a cyclin‐dependent kinase inhibitor
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CTGF
  - PTK2
  - DBF4
  - MAPK8
  - MAPK9
  - MAPK10
  - MAPK14
  - MAPK11
  - MAPK13
  - MAPK12
  - PPARA
  - CHUK
  - IKBKG
  - IKBKB
  - MAPK3
  - MAPK1
  - JUN
  - NFKBIA
  - CXCL8
  - IL6
  - IL1B
  - CCL2
  - TP53
  - VCAM1
  - TF
  - ICAM1
  - EDN1
  - NFKB1
  - NFKB2
  - REL
  - RELA
  - RELB
  - WY-14643
  - Berberine
  - 'NO'
  - PGE2
genes:
- word: CTGF
  symbol: CTGF
  source: hgnc_symbol
  hgnc_symbol: CTGF
  entrez: '1490'
- word: FAK
  symbol: FAK
  source: hgnc_alias_symbol
  hgnc_symbol: PTK2
  entrez: '5747'
- word: ASK
  symbol: ASK
  source: hgnc_alias_symbol
  hgnc_symbol: DBF4
  entrez: '10926'
- word: JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: PPAR-a
  symbol: PPARA
  source: hgnc_symbol
  hgnc_symbol: PPARA
  entrez: '5465'
- word: IKK
  symbol: IKK
  source: bioentities_symbol
  hgnc_symbol: CHUK
  entrez: '1147'
- word: IKK
  symbol: IKK
  source: bioentities_symbol
  hgnc_symbol: IKBKG
  entrez: '8517'
- word: IKK
  symbol: IKK
  source: bioentities_symbol
  hgnc_symbol: IKBKB
  entrez: '3551'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: c-Jun
  symbol: c-Jun
  source: hgnc_alias_symbol
  hgnc_symbol: JUN
  entrez: '3725'
- word: IKBa
  symbol: IKBA
  source: hgnc_alias_symbol
  hgnc_symbol: NFKBIA
  entrez: '4792'
- word: c-Jun
  symbol: c-Jun
  source: hgnc_alias_symbol
  hgnc_symbol: JUN
  entrez: '3725'
- word: IL-6,IL-8,
  symbol: IL-8
  source: hgnc_alias_symbol
  hgnc_symbol: CXCL8
  entrez: '3576'
- word: IL-6,IL-8,
  symbol: IL-6
  source: hgnc_alias_symbol
  hgnc_symbol: IL6
  entrez: '3569'
- word: IL-6,
  symbol: IL-6
  source: hgnc_alias_symbol
  hgnc_symbol: IL6
  entrez: '3569'
- word: IL-8,
  symbol: IL-8
  source: hgnc_alias_symbol
  hgnc_symbol: CXCL8
  entrez: '3576'
- word: IL-1B
  symbol: IL-1B
  source: hgnc_alias_symbol
  hgnc_symbol: IL1B
  entrez: '3553'
- word: MCP-1
  symbol: MCP-1
  source: hgnc_alias_symbol
  hgnc_symbol: CCL2
  entrez: '6347'
- word: p53
  symbol: p53
  source: hgnc_alias_symbol
  hgnc_symbol: TP53
  entrez: '7157'
- word: NO,PGE2,VCAM-1,
  symbol: VCAM1
  source: hgnc_symbol
  hgnc_symbol: VCAM1
  entrez: '7412'
- word: VCAM-1,
  symbol: VCAM1
  source: hgnc_symbol
  hgnc_symbol: VCAM1
  entrez: '7412'
- word: TF
  symbol: TF
  source: hgnc_symbol
  hgnc_symbol: TF
  entrez: '7018'
- word: ICAM-1,ET-1,andTF
  symbol: ICAM1
  source: hgnc_symbol
  hgnc_symbol: ICAM1
  entrez: '3383'
- word: ICAM-1,
  symbol: ICAM1
  source: hgnc_symbol
  hgnc_symbol: ICAM1
  entrez: '3383'
- word: ET-1,
  symbol: ET1
  source: hgnc_alias_symbol
  hgnc_symbol: EDN1
  entrez: '1906'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB2
  entrez: '4791'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: REL
  entrez: '5966'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELA
  entrez: '5970'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELB
  entrez: '5971'
- word: IL-6
  symbol: IL-6
  source: hgnc_alias_symbol
  hgnc_symbol: IL6
  entrez: '3569'
chemicals:
- word: WY-14643
  source: MESH
  identifier: C006253
- word: Berberine
  source: MESH
  identifier: D001599
- word: 'NO'
  source: ''
  identifier: ''
- word: PGE2
  source: MESH
  identifier: D015232
diseases: []
figid_alias: PMC7520283__F3
redirect_from: /figures/PMC7520283__F3
figtype: Figure
---
